A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...
Cells were long believed to safeguard nuclear contents, releasing them only during cell death. Extracellular DNA was thought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results